Chen, Po-WeiPo-WeiChenSu, Hsiao-YuanHsiao-YuanSuYU-KANG TUWu, Chih-HsingChih-HsingWuYeh, Jih-IJih-IYehChen, Li-YuLi-YuChenPeng, Carol Chiung-HuiCarol Chiung-HuiPengLoh, Ching-HuiChing-HuiLohHuang, Huei-KaiHuei-KaiHuangLin, Shu-ManShu-ManLin2023-03-252023-03-252023-020937-941Xhttps://scholars.lib.ntu.edu.tw/handle/123456789/629689Previous evidence suggests that bisphosphonates may improve glycemic control. The present meta-analysis, comprising seven studies with 1,233,844 participants, demonstrated that bisphosphonate use was significantly associated with a lower risk of diabetes. However, in the randomized controlled trial subgroup, a non-significant association was found. Further studies are needed to determine causality.enBisphosphonates; Diabetes mellitus; Glycemic control; Meta-analysis; Osteoporosis[SDGs]SDG3[SDGs]SDG5journal article10.1007/s00198-022-06616-3364646992-s2.0-85143293139WOS:000893903400001https://api.elsevier.com/content/abstract/scopus_id/85143293139